Follow-up of patients after Helicobacter pylori eradication;Quelle surveillance après éradication d'Helicobacter pylori?

Revue du Praticien

Volumn 64, Issue 2, 2014, Pages 211-214

  Courillon Mallet, Anne ^a  

^a Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATROPHY; CANCER PREVENTION; CANCER RISK; CHRONIC DISEASE; DISEASE ERADICATION; DYSPLASIA; FOLLOW UP; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; STOMACH CANCER; STOMACH MUCOSA;

CONTINUITY OF PATIENT CARE; EARLY DETECTION OF CANCER; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRECANCEROUS CONDITIONS; RECURRENCE;

EID: 84895755160     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Take S, Mizuno M, Ishiki K, et al. Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol 2012;47:641-6.
2. Halitim F, Vincent P, Michaud L, et al. High rate of Helicobacter pylori reinfection in children and adolescents. Helicobacte 2006;11:168-72. (Pubitemid 43736551)
3. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-65. (Pubitemid 351342074)
4. Genta RM, Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut 1999;45:15-8.
5. Den Hoed CM, Holster IL, Capelle LG, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy 2013;45:249-56.
6. Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31:1104-11.
7. Dinis-Ribeiro M, de Vries AC, Marcos-Pinto R, et al.; European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94.